for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Amarin Says Eicosapentaenoic Acid Levels From Vascepa In Reduce-It® Strongly Correlated With Cardiovascular Outcomes

March 30 (Reuters) - Amarin Corporation PLC:

* EICOSAPENTAENOIC ACID (EPA) LEVELS FROM VASCEPA® (ICOSAPENT ETHYL) IN REDUCE-IT® STRONGLY CORRELATED WITH CARDIOVASCULAR OUTCOMES

* AMARIN CORPORATION - SERUM EPA LEVELS SHOWED APPROXIMATELY 400% INCREASE FOLLOWING ADMINISTRATION OF VASCEPA

* AMARIN CORPORATION- FOLLOWING ADMINISTRATION OF VASCEPA, DHA LEVELS WERE MEASURED AND SHOWED A DECREASE OF 2.9% Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up